Gleevec, approved 25 years ago, revolutionized cancer treatment by targeting genetic causes instead of toxic chemotherapy. Patients like Mel Mann, given three years to live, now run marathons. This breakthrough ushered in over 100 targeted drugs, though pricing remains a challenge.
Gleevecs 25-Year Legacy: Cancer Death Sentence Reversed
✨ Enjoying this article? ✨
📱 Get more with the NewsNuggs iOS App →